Aneuploidy Landscape in Precursors of Ovarian Cancer

Author:

Wang Yeh1ORCID,Douville Christopher2345ORCID,Chien Yen-Wei1ORCID,Wang Brant G.678ORCID,Chen Chi-Long9ORCID,Pinto Andre10ORCID,Smith Saron Ann11ORCID,Drapkin Ronny12ORCID,Chui M. Herman13ORCID,Numan Tricia114ORCID,Vang Russell1ORCID,Papadopoulos Nickolas1235ORCID,Wang Tian-Li1515ORCID,Shih Ie-Ming1515ORCID

Affiliation:

1. 1Department of Pathology, Johns Hopkins Medical Institutions, Baltimore, Maryland.

2. 2Department of Oncology, the Sidney Kimmel Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland.

3. 3The Ludwig Center, Johns Hopkins University School of Medicine, Baltimore, Maryland.

4. 4The Sol Goldman Pancreatic Cancer Research Center, Johns Hopkins University School of Medicine, Baltimore, Maryland.

5. 5Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins Medical Institutions, Baltimore, Maryland.

6. 6Department of Pathology, Inova Fairfax Hospital, Falls Church, Virginia.

7. 7School of Medicine Inova Campus, University of Virginia, Falls Church, Virginia.

8. 8Department of Pathology, Georgetown University Medical Center, Washington, DC.

9. 9Department of Pathology, College of Medicine, Taipei Medical University, Taipei, Taiwan.

10. 10University of Miami Sylvester Comprehensive Cancer Center, Miami, Florida.

11. 11Cascade Pathology Services, Legacy Health System, Portland, Oregon.

12. 12Department of Obstetrics and Gynecology and Basser Center for BRCA, University of Pennsylvania, Philadelphia, Pennsylvania.

13. 13Department of Pathology and Laboratory Medicine, Sloan-Kettering Cancer Center, New York, New York.

14. 14Department of Pathology, Sibley Memorial Hospital, Washington, DC.

15. 15Department of Gynecology and Obstetrics, Johns Hopkins Medical Institutions, Baltimore, Maryland.

Abstract

Abstract Purpose: Serous tubal intraepithelial carcinoma (STIC) is now recognized as the main precursor of ovarian high-grade serous carcinoma (HGSC). Other potential tubal lesions include p53 signatures and tubal intraepithelial lesions. We aimed to investigate the extent and pattern of aneuploidy in these epithelial lesions and HGSC to define the features that characterize stages of tumor initiation and progression. Experimental Design: We applied RealSeqS to compare genome-wide aneuploidy patterns among the precursors, HGSC (cases, n = 85), and histologically unremarkable fallopian tube epithelium (HU-FTE; control, n = 65). On the basis of a discovery set (n = 67), we developed an aneuploidy-based algorithm, REAL-FAST (Repetitive Element AneupLoidy Sequencing Fallopian Tube Aneuploidy in STIC), to correlate the molecular data with pathology diagnoses. We validated the result in an independent validation set (n = 83) to determine its performance. We correlated the molecularly defined precursor subgroups with proliferative activity and histology. Results: We found that nearly all p53 signatures lost the entire Chr17, offering a “two-hit” mechanism involving both TP53 and BRCA1 in BRCA1 germline mutation carriers. Proliferatively active STICs harbor gains of 19q12 (CCNE1), 19q13.2, 8q24 (MYC), or 8q arm, whereas proliferatively dormant STICs show 22q loss. REAL-FAST classified HU-FTE and STICs into 5 clusters and identified a STIC subgroup harboring unique aneuploidy that is associated with increased proliferation and discohesive growth. On the basis of a validation set, REAL-FAST showed 95.8% sensitivity and 97.1% specificity in detecting STIC/HGSC. Conclusions: Morphologically similar STICs are molecularly distinct. The REAL-FAST assay identifies a potentially “aggressive” STIC subgroup harboring unique DNA aneuploidy that is associated with increased cellular proliferation and discohesive growth. REAL-FAST offers a highly reproducible adjunct technique to assist the diagnosis of STIC lesions.

Funder

Department of Pathology, Johns Hopkins University

Honorable Tina Brozman Foundation

Break Through Cancer

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3